最新文章:伊维菌素和甲苯咪唑治疗案例:一位86岁俄勒冈州男性,患有二期肾细胞癌,

复利生息 2025-11-17 13:08:13

最新文章:伊维菌素和甲苯咪唑治疗案例:一位86岁俄勒冈州男性,患有二期肾细胞癌,三个月后汇报病情癌症患者使用老药新用药物治疗没有年龄限制! 😃故事:一名86岁的俄勒冈州男子患有二期肾细胞癌他服用了以下药物,持续了3个月:伊维菌素 100 毫克/天甲苯咪唑 1000 毫克/天结果:肾脏肿瘤从 2.7x1.5cm 缩小到 2.7x0.9cm(根据 Grok 的测量,肿瘤体积减少了 64%)。“没有改进”来自患者家属:“医生非常满意,并计划一年后带XXX(病人)去做新的核磁共振检查。”来自一位一窍不通的肿瘤科医生:( 😃“好消息。核磁共振检查未发现肿瘤复发迹象。我们计划一年后再做一次核磁共振检查。”是的,就是这么简单。我拥有全球最大的伊维菌素癌症患者群体。我们在癌症治疗领域处于最前沿。NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial: 86 year old Oregon man with Stage 2 Renal Cell Carcinoma reports after 3 monthsThere is NO AGE LIMIT for cancer patients getting help from repurposed drugs! 😃STORY:86 year old Oregon man with Stage 2 Renal Cell CarcinomaFor 3 months he took:Ivermectin 100mg/dayMebendazole 1000mg/dayResult:Kidney tumor shrunk from 2.7x1.5cm to 2.7x0.9cm (64% tumor volume reduction according to Grok)."There is no enhancement"From patient's family:"doctor is very satisfied and plans on checking with XXX (patient) in another year with a new MRI"From clueless Oncologist: 😃"Great News. No concern for tumor recurrence on MRI. Let's plan for another MRI in a year."Yes, it's literally THAT EASY.I have the world's largest Ivermectin Cancer Clientele.We are at the cutting edge of Cancer Care.

0 阅读:0
复利生息

复利生息

感谢大家的关注